![David Goldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Goldstein
Chief Tech/Sci/R&D Officer at
ALUMIS INC.
Net worth: 5 M $ as of 2026-05-30
Profile
Dr. David M.
Goldstein is a Chief Scientific Officer at Alumis, Inc. and a Meetings Manager at International Society for Pharmacoeconomics & Outcomes Rsch.
He is on the Board of Directors at Frontier Medicines Corp.
Dr. Goldstein was previously employed as a Chief Scientific Officer by Principia Biopharma, Inc., a Senior Director-Medicinal Chemistry by Roche Holding AG, and an Assistant Professor by Stanford University.
He received his undergraduate degree from Franklin & Marshall College and a doctorate degree from the University of Virginia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALUMIS INC. 0.18% | 2026-05-04 | 221,620 ( 0.18% ) | 5 M $ | 2026-05-30 |
David Goldstein active positions
| Companies | Position | Start |
|---|---|---|
| ALUMIS INC. | Chief Tech/Sci/R&D Officer | 2021-08-31 |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Director/Board Member | 2021-03-29 |
International Society for Pharmacoeconomics & Outcomes Rsch
 International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services Provides health care researches | Corporate Officer/Principal | - |
Former positions of David Goldstein
| Companies | Position | End |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2020-08-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2010-12-31 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of David Goldstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Society for Pharmacoeconomics & Outcomes Rsch
International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services Provides health care researches | Commercial Services |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
- Stock Market
- Insiders
- David Goldstein
